Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-06-24
1993-11-09
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142372, 514319, 514321, 514326, 544130, 546190, 546198, 546201, 546205, 546231, A61K 31445, A61K 31535, C07D40112, C07D41312
Patent
active
052603075
ABSTRACT:
Compounds of the formula ##STR1## wherein L, M, R, T and X are set forth in the description, as well as hydrates or solvates thereof, which inhibit thrombin-induced platelet aggregation and clotting of fibrinogen in plasma, are described. The compounds of formula I are prepared by amidination or, depending on whether L is NH or O, by amide formation or esterification.
REFERENCES:
patent: 4227006 (1980-10-01), Okamoto et al.
patent: 4258192 (1981-03-01), Okamoto et al.
patent: 4879313 (1989-11-01), Tjoeng et al.
patent: 5037808 (1991-08-01), Tjoeng et al.
patent: 5053393 (1991-10-01), Tjoeng et al.
J. Med. Chem. 23, 1980, 1293-9.
Pharmazie 39, 1984, 226-230.
Ackermann Jean
Banner David
Gubernator Klaus
Hadvary Paul
Hilpert Kurt
Gould George M.
Hofmann-La Roche Inc.
Johnston George W.
Krovatin William
Ramsuer Robert W.
LandOfFree
Guanidine derivatives compositions and use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Guanidine derivatives compositions and use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Guanidine derivatives compositions and use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1142985